The frequency of invariant natural killer T cells correlates with the severity of myocarditis.
暂无分享,去创建一个
Yuying | LiMinghui | Yuyong | WangXinggang | XieYeqing | LiuGuijian | YangXiangdong | Zouyunzeng | GEJun-bo | ChenRuizhen
[1] Wei Liu,et al. Cross-regulation of T regulatory-cell response after coxsackievirus B3 infection by NKT and γδ T cells in the mouse. , 2013, The American journal of pathology.
[2] S. Jonjić,et al. The evolutionary arms race between NK cells and viruses: Who gets the short end of the stick? , 2013, European journal of immunology.
[3] Vrajesh V. Parekh,et al. Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells , 2013, The Journal of Immunology.
[4] S. Huber,et al. Slam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis. , 2013, The American journal of pathology.
[5] M. Smyth,et al. Transient Foxp3+ regulatory T‐cell depletion enhances therapeutic anticancer vaccination targeting the immune‐stimulatory properties of NKT cells , 2013, Immunology and cell biology.
[6] J. Ge,et al. Initial weight and virus dose: two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse--a histopathology-based study. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[7] D. Chang,et al. Modulatory Function of Invariant Natural Killer T Cells in Systemic Lupus Erythematosus , 2012, Clinical & developmental immunology.
[8] Ikuo Tsunoda,et al. Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis. , 2012, Future virology.
[9] J. Ge,et al. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart. , 2012, FEMS immunology and medical microbiology.
[10] P. Carmeliet,et al. Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells. , 2012, Cardiovascular research.
[11] L. Cooper,et al. Republished: Pathogenesis and diagnosis of myocarditis , 2012, Postgraduate Medical Journal.
[12] L. Cooper,et al. Update on myocarditis. , 2012, Journal of the American College of Cardiology.
[13] C. Guzmán,et al. NKT Cell Stimulation with α-Galactosylceramide Results in a Block of Th17 Differentiation after Intranasal Immunization in Mice , 2012, PloS one.
[14] J. Ge,et al. The role of Th17 cells and regulatory T cells in Coxsackievirus B3-induced myocarditis. , 2011, Virology.
[15] G. Qian,et al. α‐Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis , 2010, Clinical and experimental immunology.
[16] B. McManus,et al. Regulating viral myocarditis: allografted regulatory T cells decrease immune infiltration and viral load. , 2010, Circulation.
[17] Hyunji Lee,et al. Natural killer T cells promote collagen-induced arthritis in DBA/1 mice. , 2009, Biochemical and biophysical research communications.
[18] Hiroyasu Ito,et al. Valpha14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes. , 2009, Biochemical and biophysical research communications.
[19] Y. Ishii,et al. Characterization of the immature dendritic cells and cytotoxic cells both expanded after activation of invariant NKT cells with alpha-galactosylceramide in vivo. , 2008, Biochemical and biophysical research communications.
[20] M. Taniguchi,et al. Methods for detection, isolation and culture of mouse and human invariant NKT cells , 2007, Nature Protocols.
[21] S. Huber,et al. Role of CD1d in Coxsackievirus B3-Induced Myocarditis 1 , 2003, The Journal of Immunology.
[22] J. Mosnier,et al. Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. , 2000, Circulation.